Navigation Links
United States Recognizes Leading Scottish Scientist for Disease Research
Date:4/22/2009

Sir Philip Cohen to be inducted into National Academy of Sciences for groundbreaking work in biochemistry and biology

WASHINGTON, April 22 /PRNewswire/ -- Sir Philip Cohen of Scotland's University of Dundee will be inducted into the U.S. National Academy of Sciences (NAS) during its 146th annual meeting on Saturday, April 25 at 8:00 p.m. at the NAS building for his excellence in original scientific research. Sir Philip is one of only four Scottish scientists ever inducted into the NAS, one of the highest honors given to a scientist or engineer in the United States and a rare honor for non-U.S. scientists.

As Director of the MRC Protein Phosphorylation Unit and the Scottish Institute for Cell Signalling at the University of Dundee, Sir Philip has advanced the field of biochemistry. In particular, he has studied abnormal protein phosphorylation as a cause or consequence of cancer, diabetes and inflammatory disease. Under Sir Philip's direction, scientists have identified new proteins as targets for a number of breakthrough therapies today, as well as new diabetes and cancer drugs in development. For instance, protein kinase inhibitors have been approved for clinical use as anti-cancer agents, including Gleevec, a drug that has helped turn a previously fatal form of leukemia into a manageable disease.

Sir Philip's contribution to the field of life sciences is demonstrated by his longstanding commitment to collaboration across the industry. Recently, Sir Philip helped identify the Ubiquitin Proteasome System (UPS) as a promising new source for key drug targets and is part of a global UPS research program partnering life sciences company Millipore with the Universities of Glasgow, Strathclyde and Edinburgh, and Mount Sinai Hospital in Toronto.

"I believe this recognition is a testament to Scotland's longstanding commitment to advancing cutting-edge disease research, as well as its efforts to foster an environment where scientific innovation can thrive," said Sir Philip. "I am deeply honored by this distinction, especially as a scientist outside of the U.S."

Since being appointed to a Lectureship in Dundee in October 1971, Sir Philip was elected a Fellow of both The Royal Society of London and The Royal Society of Edinburgh in 1984, was knighted by the Queen in 1998 and has received honorary doctorates from five Universities. He was the world's second most cited scientist from 1993-2003 in the field of Biology and Biochemistry and has been instrumental in attracting a range of companies and world-class scientists to the University of Dundee.

There are currently just over 2,000 active NAS members. Among the NAS's renowned members are Albert Einstein, Robert Oppenheimer, Thomas Edison, Orville Wright, and Alexander Graham Bell. Over 180 living Academy members have won Nobel Prizes.

About The National Academy of Sciences

The National Academy of Sciences is a private, nonprofit honorific society of distinguished scholars engaged in scientific and engineering research, dedicated to the furthering science and technology and to their use for the general welfare. For more information, or for the full list of newly elected members, visit http://www.nasonline.org/site/PageServer.


'/>"/>
SOURCE University of Dundee
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
2. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
3. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
4. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
5. Biomira Announces Plan to Reincorporate in the United States
6. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
7. InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom
8. United BioSource Acquires Caro Research, Leader in Simulation Modeling
9. ThalesNano Inc. Opens Own Representation in the United Kingdom and has New Distribution Agreements for Europe and India
10. ISTO Technologies Granted Key Patent for Cartilage Cell Expansion by the United States Patent Office
11. Bioponic Phytoceuticals to Roll Out Multiple Products to 1,000 Major Health Food Stores in the Western United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Regular discussions on a range of subjects ... the two entities said Poloz. Speaking at a ... , he pointed to the country,s inflation target, which ... "In certain areas ... have common economic goals, why not sit down and address ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... Md. , June 23, 2016 A person ... from the crime scene to track the criminal down. ... the U.S. Food and Drug Administration (FDA) uses DNA evidence ... Sound far-fetched? It,s not. The FDA ... sequencing to support investigations of foodborne illnesses. Put as simply ...
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
Breaking Biology Technology:
(Date:5/24/2016)... facilitates superior patient care by providing unparalleled technology to leaders of the medical imaging ... product recently added to the range of products distributed by Ampronix. Photo ... ... ... News ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
Breaking Biology News(10 mins):